KRAS mutation	Colorectal Cancer	KRAS mutation	Colorectal Cancer	HMG-CoA reductase inhibitor + oxaliplatin Sensitive: C2 – Inclusion Criteria HMG-CoA reductase inhibitor + oxaliplatin Sensitive : C2	HMG-CoA reductase inhibitor + oxaliplatin Sensitive: C2 – Inclusion Criteria HMG-CoA reductase inhibitor + oxaliplatin Sensitive : C2
ACSL3 overexpression	Lung Non-Small Cell Squamous Cancer	ACSL3 overexpression	Lung Non-Small Cell Squamous Cancer	ezetimibe/simvastatin Sensitive: C3 – Early Trials ezetimibe / simvastatin Sensitive : C3	ezetimibe/simvastatin Sensitive: C3 – Early Trials ezetimibe / simvastatin Sensitive : C3
HER-2 overexpression	Breast Cancer	HER-2 overexpression	Breast Cancer	simvastatin Sensitive: C3 – Early Trials simvastatin Sensitive : C3	simvastatin Sensitive: C3 – Early Trials simvastatin Sensitive : C3
CAV1 expression	Non Small Cell Lung Cancer	CAV1 expression	Non Small Cell Lung Cancer	amlodipine/atorvastatin Sensitive: D – Preclinical amlodipine / atorvastatin Sensitive : D	amlodipine/atorvastatin Sensitive: D – Preclinical amlodipine / atorvastatin Sensitive : D
APC mutation	Colorectal Cancer	APC mutation	Colorectal Cancer	HMG-CoA reductase inhibitor Sensitive: D – Preclinical HMG-CoA reductase inhibitor Sensitive : D	HMG-CoA reductase inhibitor Sensitive: D – Preclinical HMG-CoA reductase inhibitor Sensitive : D
TP53 mutation	Breast Cancer	TP53 mutation	Breast Cancer	docetaxel + simvastatin Sensitive: D – Preclinical docetaxel + simvastatin Sensitive : D	docetaxel + simvastatin Sensitive: D – Preclinical docetaxel + simvastatin Sensitive : D
TP53 mutation	Breast Cancer	TP53 mutation	Breast Cancer	doxorubicin hydrochloride + simvastatin Sensitive: D – Preclinical doxorubicin hydrochloride + simvastatin Sensitive : D	doxorubicin hydrochloride + simvastatin Sensitive: D – Preclinical doxorubicin hydrochloride + simvastatin Sensitive : D
TP53 mutation	Breast Cancer	TP53 mutation	Breast Cancer	simvastatin Sensitive: D – Preclinical simvastatin Sensitive : D	simvastatin Sensitive: D – Preclinical simvastatin Sensitive : D
TP53 mutation	Breast Cancer	TP53 mutation	Breast Cancer	atorvastatin Sensitive: D – Preclinical atorvastatin Sensitive : D	atorvastatin Sensitive: D – Preclinical atorvastatin Sensitive : D

HMG-CoA reductase inhibitor

HMG-CoA reductase inhibitor

Associations(9)

Associations
(9)